skip to main content
Lindsay Neidrauer

Lindsay Neidrauer

Direct: 416.863.3352
Fax: 416.863.9171

Lindsay Neidrauer is an accomplished litigator with extensive experience in pharmaceutical and biotechnology patent litigation. Lindsay represents clients in all areas of intellectual property litigation including patents, trademarks and copyright. She regularly appears in the Federal Court and Federal Court of Appeal.

After graduating with a B.Sc.H. degree from Queen’s University, Lindsay went on to study at the University of Toronto’s Faculty of Law. She was called to the Ontario Bar in 2003 after graduating with a JD. Lindsay also holds an MA in criminology and is a registered trade-mark agent.

Throughout her career, Lindsay’s practice has focused primarily in the areas of biotechnology and pharmaceuticals. She has been fortunate to work with leading scientific experts – including a Nobel Prize winner – in scientifically complex cases. Her passion, commitment and drive give her an edge when it comes to providing clients with the best possible representation. She is adept at identifying key issues, devising and carrying out strategies, and advocating her clients’ positions. Lindsay prides herself on not only her advocacy skills, but also in working with clients to achieve the best possible outcome for their cases.

Lindsay’s interest in and enthusiasm for intellectual property law extends beyond client work. She is a member of the Litigation Committee of the Intellectual Property Institute of Canada.  She is also a co-author of the chapter on Canada in “Intellectual Property in the Life Sciences”.


  • Called to the Ontario Bar, 2003
  • University of Toronto, J.D., 2002
  • University of Toronto, MA in Criminology, 2002
  • Queen’s University, B.Sc.H., Biology, 1998


  • IAM Patent 1000: The World’s Leading Patent Professionals 2018: Litigation
  • Managing Intellectual Property IP Star 2018
  • 2016 IP Star, Managing Intellectual Property 
  • IAM Patent 1000: The World's Leading Patent Professionals 2016: Litigation 
  • 2015 IP Star, Managing Intellectual Property
  • Lawyer Monthly Women in Law Award
  • Intellectual Asset Management’s IAM Patent 1000- Guide to the World’s Leading Patent Practitioners
  • Managing Intellectual Property IP Star: Patent litigation; Patent strategy counseling


Date Title Type
Dec 01, 2011 Intellectual Property in the Life Sciences, Canada Chapter 2011 A Global Guide to Rights and Their Applications (Globe Business Publishing Ltd 2011) Book


Date Case Title Expertise
May 04, 2015 2015 FCA 116 Cobalt Pharmaceuticals Company v. Bayer Inc.
We successfully represented Bayer in appeals from a decision of the Federal Court regarding patents covering oral contraceptives containing drospir...


Oct 01, 2014 Court File No. A-45-14 Takeda v. Apotex
We represented Takeda on appeals from a section 8 damages action relating to pantoprozole (PANTOLOC®). The appeals were resolved prior to a hea...


May 07, 2014 2014 FC 436 Bayer Inc. and Bayer Pharma Aktiengesellschaft v. Apotex Inc. and the Minister of Health
The validity of Bayer’s key patent covering the oral contraceptives YASMIN® and YAZ® was upheld by the Federal Court.


Feb 14, 2014 2014 FC 149 Alcon Canada Inc. v. Cobalt Pharmaceuticals Company - 2014 FC 149
This case involves an application for an order in the nature of prohibition to restrain the Minister of Health from issuing a Notice of Compliance ...


Dec 11, 2013 2013 FC 1237 Apotex Inc. v. Takeda Canada Inc.
We represented Takeda in defending a damages case pursuant to section 8 of the Patented Medicines (Notice of Compliance) Regulations.


More Cases


  • Intellectual Property Institute of Canada (IPIC), Member of Litigation Committee 
  • American Bar Association – Intellectual Property Section 
  • American Intellectual Property Law Association (AIPLA) 
  • Association International pour la Protection de la Propriété Intellectuelle (AIPPI)
Lindsay Neidrauer

Lindsay Neidrauer 


Direct: 416.863.3352
Fax: 416.863.9171

© 2015 Belmore Neidrauer LLP | Legal Disclaimer | Privacy Policy